WHO Establishes New Collaborating Centre in UK to Combat Rising Liver Disease

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-24
Category: health
Source: WHO
Original source

The World Health Organization (WHO), in partnership with Imperial College London and the European Association for the Study of the Liver (EASL), has launched its first collaborating centre in the United Kingdom dedicated to liver disease. This initiative aims to address the alarming rise in liver disease across the WHO European Region, which accounts for approximately 780 deaths daily and significant healthcare costs. The center will focus on translating evidence-based policies, including restrictions on unhealthy food and alcohol marketing, into practical actions.

Context

Liver disease has been on the rise in many parts of the world, particularly in the WHO European Region. This increase has led to significant mortality rates and economic burdens on healthcare systems. The collaboration between the WHO, Imperial College London, and EASL represents a concerted effort to tackle this issue through research and policy development.

Why it matters

The establishment of the WHO's new collaborating centre in the UK is crucial in addressing the growing public health crisis of liver disease. With around 780 deaths daily attributed to this condition in the European Region, the initiative aims to implement effective strategies to reduce its prevalence. By focusing on policy translation, the centre seeks to create a healthier environment through better regulation of food and alcohol marketing.

Implications

The new centre may lead to significant changes in public health policy regarding liver disease prevention. Individuals at risk of liver disease, particularly those affected by unhealthy lifestyle choices, may benefit from improved health initiatives. Healthcare providers and policymakers will need to adapt to new guidelines and practices emerging from this collaboration.

What to watch

In the near term, the centre will begin to roll out evidence-based policies aimed at reducing liver disease rates. Observers should monitor how effectively these policies are implemented and their impact on public health. Additionally, any forthcoming research from the centre could provide insights into effective interventions and strategies.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai